Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxazepam
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxazepam 10mg tablets
0401020T0AAABAB
|
Oxazepam | Oxazepam | Central Nervous System | 9,664 |
|
Oxazepam 15mg tablets
0401020T0AAACAC
|
Oxazepam | Oxazepam | Central Nervous System | 4,279 |
|
Oxazepam 10mg/5ml oral suspension
0401020T0AAAJAJ
|
Oxazepam | Oxazepam | Central Nervous System | 2 |
|
Oxazepam 12.5mg/5ml oral suspension
0401020T0AAAIAI
|
Oxazepam | Oxazepam | Central Nervous System | No data available |
|
Oxazepam 2.5mg/5ml oral suspension
0401020T0AAAHAH
|
Oxazepam | Oxazepam | Central Nervous System | No data available |
|
Oxazepam 2mg/5ml oral suspension
0401020T0AAAKAK
|
Oxazepam | Oxazepam | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.